The artificial organs market share is forecast to reach USD 13,089.17 million, after growing at a CAGR of 9.14% during 2023-2027. The increasing prevalence of chronic disorders is analyzed to boost the addiction therapeutics market growth. Moreover, the emergence of TAH is the major trend enhancing the overall market demand for artificial organs during the forecast period.
Get a snapshot of the artificial organs market analysis: Unlock the Sample Report
Browse Technavio's 170-page report and in-depth TOC on "Artificial Organs Market by product (artificial heart, artificial kidney, cochlear implants, and artificial pancreas), usage (implantable and extracorporeal), and geography (North America, Europe, Asia, and the Rest Of World (ROW))."
View detailed Table of Contents Here: https://www.technavio.com/report/artificial-organs-market-industry-analysis
Artificial Heart: The artificial organ market growth by the artificial heart segment will be significant during the forecast period. The growing demand and technological advances in implantable cardiac pacemakers have increased their adoption, which will help the market achieve the fastest growth rate during the forecast period.
North America: 46% of market growth will develop from North America during the forecast period. The growing prevalence and incidence of chronic diseases such as diabetes, cardiovascular diseases, and CKD also contribute to the growth of the market in the region.
Europe
Asia
Rest of World (ROW)
Implantable
Extracorporeal
The artificial organs market size will witness a YOY Growth Rate of 8.56% in 2023.
The complications and limitations of artificial organs will be a major challenge for the artificial organ market during the forecast period.
Major key artificial organ market players include: Abbott Laboratories, Asahi Kasei Corp., B. Braun SE, Baxter International Inc., BioTelemetry Inc., BIOTRONIK SE and Co. KG, BiVACOR Inc., Boston Scientific Corp., Cochlear Ltd., F. Hoffmann La Roche Ltd., Fresenius Medical Care AG and Co. KGaA, Insulet Corp., MED EL Elektromedizinische Gerate GmbH, Medtronic Plc, Nihon Kohden Corp., Nikkiso Co. Ltd., Nipro Pharma Packaging International NV, Sonova AG, SynCardia Systems LLC, and Tandem Diabetes Care Inc.
The report illustrates the lifecycle of the market, focusing on the adoption rates of the major regions such as the North America, Europe, Asia, and Rest of World (ROW)
Download the PDF sample report for highlights on the market size, growth momentum, regional growth opportunities, vendor analysis, and other factors influencing the market growth.
Precise market size estimation during the forecast period 2023-2027.
CAGR of the artificial organs market forecast during 2023-2027.
Market-level data on units, average selling prices, and values of the artificial organs market share.
Prediction of the upcoming trends, drivers, and factors that challenge the growth of the artificial organ market.
Artificial organ industry growth across North America, Europe, Asia, and Rest of World (ROW).
Communication Services
Consumer Discretionary
Consumer Staples
Energy
Financials
Health Care
Industrials
Information Technology
Materials
Utilities